Pheon Therapeutics Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 31

Employees

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $151M

  • Investors
  • 11

Pheon Therapeutics General Information

Description

Developer of antibody-drug conjugates designed to treat hard-to-treat solid tumors. The company's pipeline utilizes novel targets and proprietary linker-payload technologies to facilitate the creation of first-in-class oncology assets, enabling healthcare providers to access next-generation therapies for cancer types that have not responded to conventional treatments.

Contact Information

Website
www.pheontx.com
Formerly Known As
Femtogenix
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Innovation House, Innovation Way
  • Discovery Park
  • CT13 9FF
  • England, United Kingdom
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • Innovation House, Innovation Way
  • Discovery Park
  • CT13 9FF
  • England, United Kingdom

Pheon Therapeutics Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Pheon Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC (Series B) 21-May-2024 $151M Completed Clinical Trials - Phase 1
4. Later Stage VC (Series A2) 04-Mar-2024 Completed Clinical Trials - Phase 1
3. Early Stage VC (Series A) 31-Jan-2018 Completed Startup
2. Early Stage VC (Series A) 19-Oct-2015 $3.53M $3.53M Completed Startup
1. University Spin-Out 08-Jul-2015 Completed Startup
To view Pheon Therapeutics’s complete valuation and funding history, request access »

Pheon Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B
Series A 2 Preferred
Series A 2 Preferred 25,046,180 $0.000125 $2.38 $2.38 1x $2.38 44.36%
Series A 3,800,000 $0.000125 $1.25 $1.25 1x $1.25 6.73%
To view Pheon Therapeutics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Pheon Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of antibody-drug conjugates designed to treat hard-to-treat solid tumors. The company's pipeline utilizes nove
Drug Discovery
United Kingdom
31 As of 2026

Prague, Czech Republic
 

Cambridge, United Kingdom
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Pheon Therapeutics Competitors (9)

One of Pheon Therapeutics’s 9 competitors is Sotio Biotech, a Pending Transaction (VC) company based in Prague, Czech Republic.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Sotio Biotech Pending Transaction (VC) Prague, Czech Republic
STORM Therapeutics Venture Capital-Backed Cambridge, United Kingdom
Adaptimmune Therapeutics Formerly VC-backed Abingdon, United Kingdom
Myricx Bio Formerly VC-backed London, United Kingdom
Araris Formerly VC-backed Zurich, Switzerland
You’re viewing 5 of 9 competitors. Get the full list »

Pheon Therapeutics Patents

Pheon Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026105061-A1 Antibody-drug conjugates that bind cdcp1 and uses thereof Pending 15-Nov-2024
WO-2026078443-A1 Antibody drug conjugates that bind cdcp1 and uses thereof Pending 11-Oct-2024
WO-2025262641-A1 Antibody drug conjugates that bind cdcp1 and uses thereof Pending 19-Jun-2024
WO-2025149667-A1 Antibody drug conjugates and uses thereof Inactive 12-Jan-2024
AU-2023393437-A1 Antibodies to cub domain-containing protein 1 (cdcp1) and uses thereof Pending 16-Dec-2022 A61P35/00
To view Pheon Therapeutics’s complete patent history, request access »

Pheon Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Pheon Therapeutics Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
BVF Partners Hedge Fund Minority
Lightspeed Venture Partners Venture Capital Minority
Perceptive Advisors Venture Capital Minority
TCG Crossover Management Venture Capital Minority
Atlas Venture Venture Capital Minority
You’re viewing 5 of 11 investors. Get the full list »

Pheon Therapeutics FAQs

  • When was Pheon Therapeutics founded?

    Pheon Therapeutics was founded in 2015.

  • Where is Pheon Therapeutics headquartered?

    Pheon Therapeutics is headquartered in United Kingdom.

  • What is the size of Pheon Therapeutics?

    Pheon Therapeutics has 31 total employees.

  • What industry is Pheon Therapeutics in?

    Pheon Therapeutics’s primary industry is Drug Discovery.

  • Is Pheon Therapeutics a private or public company?

    Pheon Therapeutics is a Private company.

  • What is the current valuation of Pheon Therapeutics?

    The current valuation of Pheon Therapeutics is .

  • What is Pheon Therapeutics’s current revenue?

    The current revenue for Pheon Therapeutics is .

  • How much funding has Pheon Therapeutics raised over time?

    Pheon Therapeutics has raised $222M.

  • Who are Pheon Therapeutics’s investors?

    BVF Partners, Lightspeed Venture Partners, Perceptive Advisors, TCG Crossover Management, and Atlas Venture are 5 of 11 investors who have invested in Pheon Therapeutics.

  • Who are Pheon Therapeutics’s competitors?

    Sotio Biotech, STORM Therapeutics, Adaptimmune Therapeutics, Myricx Bio, and Araris are some of the 9 competitors of Pheon Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process